Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from iSpecimen ( (ISPC) ).
On December 31, 2025, iSpecimen Inc. convened its 2025 annual meeting of stockholders but adjourned it after failing to achieve a quorum of shareholders needed to conduct business on the proposals previously circulated. The company plans to reconvene the annual meeting on January 23, 2026, maintaining November 3, 2025 as the record date, signaling an effort to secure sufficient shareholder participation to move forward with its proposed agenda.
The most recent analyst rating on (ISPC) stock is a Sell with a $0.28 price target. To see the full list of analyst forecasts on iSpecimen stock, see the ISPC Stock Forecast page.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Underperform.
The score is weighed down primarily by deteriorating financial performance (sharp revenue decline, weaker margins, ongoing losses) and persistent cash burn. Technicals also reflect a strong downtrend with bearish momentum. Corporate events add ongoing Nasdaq bid-price delisting risk despite some compliance progress and actions (reverse split approval) to address it.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
Average Trading Volume: 1,065,457
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.79M
See more insights into ISPC stock on TipRanks’ Stock Analysis page.